Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM-1 human myelodysplastic syndrome cell line

Although certain combination therapies comprising arsenic trioxide (As(2)O(3)) with other agents exist for the treatment of several types of human cancer, few As(2)O(3) combination therapies are clinically effective for myelodysplastic syndromes (MDS). Triptolide (TL) may be an effective therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Hai-Ying, Gao, Hua-Qiang, Sun, Ai-Ning, Cen, Jian-Nong, Wu, Li-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101914/
https://www.ncbi.nlm.nih.gov/pubmed/27665715
http://dx.doi.org/10.3892/mmr.2016.5779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101914/
https://www.ncbi.nlm.nih.gov/pubmed/27665715
http://dx.doi.org/10.3892/mmr.2016.5779

Ejemplares similares